Records containing: Schnitzler Syndrome

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2025-07-10
  Development of an International Multicenter Registry of Patients With Monogenic and Polygenic Autoinflammatory Diseases Aimed at Clinical and Therapeutical Data Collection and Analysis
• CLINICAL_TRIALS study record update · 2024-11-15
  A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome
• CLINICAL_TRIALS study record update · 2024-02-02
  A Pilot, Open-Label, Phase 2, Single-Center, Repeat Dose, Proof- Of-Concept Safety, Pharmacodynamics and Efficacy Study of Orally Administered Dapansutrile Capsules in Subjects With Schnitzler's Syndrome
• CLINICAL_TRIALS study record update · 2019-07-05
  Ilaris (Canakinumab) in the Schnitzler Syndrome. A Case Series.
• CLINICAL_TRIALS study record update · 2018-07-17
  A Multi-center, Double-blind, Placebo-controlled Phase II Study of the Efficacy and Safety of Canakinumab in Subjects With Schnitzler Syndrome
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2017-09-08
  Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic
• CLINICAL_TRIALS study record update · 2012-05-31
  A Single-Centre, Open Label Study of the Safety and Tolerability of Rilonacept in Subjects Living in Germany With Muckle-Wells Syndrome (MWS), a Cryopyrin-Associated Periodic Syndrome (CAPS), or Schnitzler Syndrome (SchS)
• CLINICAL_TRIALS study record update · 2012-05-24
  Efficacy and Safety of Canakinumab in Schnitzler Syndrome